相似文献
1
Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
Emerg Infect Dis. 2001 May-Jun;7(3):448-50. doi: 10.3201/eid0703.010315.
2
Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar typhi isolates showing reduced susceptibility to ciprofloxacin.
Chemotherapy. 2004 Jun;50(3):152-4. doi: 10.1159/000077890.
3
Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
Indian J Med Res. 2004 Aug;120(2):111-4.
4
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
BMC Infect Dis. 2004 Sep 20;4:36. doi: 10.1186/1471-2334-4-36.
5
Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Trop Doct. 2009 Jan;39(1):28-30. doi: 10.1258/td.2008.070452.
6
Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
J Antimicrob Chemother. 2006 Dec;58(6):1139-44. doi: 10.1093/jac/dkl391. Epub 2006 Oct 28.
7
Drug-resistant Salmonella enterica serotype paratyphi A in India.
Emerg Infect Dis. 2000 Jul-Aug;6(4):420-1. doi: 10.3201/eid0604.000420.
8
Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh.
Epidemiol Infect. 2006 Apr;134(2):433-8. doi: 10.1017/S0950268805004759.
9
Ciprofloxacin-resistant Salmonella typhi.
Natl Med J India. 1999 May-Jun;12(3):138.
10
Antimicrobial susceptibility of 128 Salmonella enterica serovar typhi and paratyphi A isolates from northern India.
Chemotherapy. 2004 Jun;50(2):88-91. doi: 10.1159/000077808.
引用本文的文献
1
WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever- key considerations and research gaps.
Gates Open Res. 2025 Sep 15;9:71. doi: 10.12688/gatesopenres.16364.1. eCollection 2025.
2
Malaria and typhoid fever among patients presenting with febrile illnesses in Ga West Municipality, Ghana.
PLoS One. 2023 May 25;18(5):e0267528. doi: 10.1371/journal.pone.0267528. eCollection 2023.
3
gyrA ser83 mutation among fluoroquinolone-resistant Salmonella enterica serovars from enteric fever patients in tertiary care hospital, Kathmandu.
BMC Microbiol. 2022 Feb 10;22(1):51. doi: 10.1186/s12866-022-02456-7.
4
Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014.
Antimicrob Resist Infect Control. 2017 Jan 5;6:2. doi: 10.1186/s13756-016-0162-z. eCollection 2017.
5
GyrA ser83 and ParC trp106 Mutations in Salmonella enterica Serovar Typhi Isolated from Typhoid Fever Patients in Tertiary Care Hospital.
J Clin Diagn Res. 2016 Jul;10(7):DC14-8. doi: 10.7860/JCDR/2016/17677.8153. Epub 2016 Jul 1.
6
Quinolones Losing Favour in Enteric Fever.
Med J Armed Forces India. 2005 Jul;61(3):308. doi: 10.1016/S0377-1237(05)80200-X. Epub 2011 May 30.
7
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.
Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15.
8
The Prevalence and Antibiotic Susceptibility Pattern of Salmonella typhi among Patients Attending a Military Hospital in Minna, Nigeria.
Adv Prev Med. 2012;2012:875419. doi: 10.1155/2012/875419. Epub 2012 Sep 28.
9
Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India.
Indian J Med Res. 2012 Jul;136(1):98-101.
10
Sacroiliitis due to Salmonella Typhi: A case report.
N Am J Med Sci. 2010 Apr;2(4):208-10.
本文引用的文献
1
Ciprofloxacin-resistant Salmonella typhi and treatment failure.
Lancet. 1999 May 8;353(9164):1590-1. doi: 10.1016/s0140-6736(99)01001-6.
2
Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan.
Lancet. 1998 Jan 31;351(9099):339. doi: 10.1016/s0140-6736(05)78338-0.
3
Quinolone-resistant Salmonella typhi in Vietnam.
Lancet. 1998 Apr 25;351(9111):1289. doi: 10.1016/s0140-6736(05)79356-9.
4
Molecular fingerprinting of multidrug-resistant Salmonella enterica serotype Typhi.
Emerg Infect Dis. 1998 Apr-Jun;4(2):317-20. doi: 10.3201/eid0402.980223.
5
Multidrug-resistant Salmonella typhi: a worldwide epidemic.
Clin Infect Dis. 1997 Jan;24 Suppl 1:S106-9. doi: 10.1093/clinids/24.supplement_1.s106.
6
Transferable chloramphenicol resistance in Salmonella typhi.
Nature. 1972 Sep 8;239(5367):109-10. doi: 10.1038/239109b0.
7
Chloramphenicol resistance in the typhoid bacillus.
Br Med J. 1972 Aug 5;3(5822):329-31. doi: 10.1136/bmj.3.5822.329.
8
Does chloramphenicol remain the drug of choice for typhoid?
Epidemiol Infect. 1987 Jun;98(3):379-83. doi: 10.1017/s0950268800062142.
9
Treatment of multiresistant typhoid fever.
Lancet. 1991 Jun 8;337(8754):1422. doi: 10.1016/0140-6736(91)93116-q.
Zotero 插件